Intensive Care Medicine

, Volume 3, Issue 2, pp 47–53 | Cite as

Haemodynamic effects of dopamine in septic shock

  • B. Regnier
  • M. Rapin
  • G. Gory
  • F. Lemaire
  • B. Teisseire
  • A. Harari


The Haemodynamic response to dopamine infusion has been assessed in 30 patients in septic shock with myocardial dysfunction. Dopamine infusion resulted in a haemodynamic improvement as indicated by significant increases in cardiac output of 38.4% (p>.001), stroke volume 18.7% (p<.001), and mean arterial pressure of 33% (p<.001). Despite the inotropic effect, left ventricular filling pressure did not change in 20 cases and increased in 10 cases. Mean peripheral resistance remained unchanged with a scatter of individual responses depending upon factors such as dopamine dose and initial vascular resistance.

Dopamine increased intrapulmonary shunting by 48% (p<.001), insignificantly decreased PaO2, increased mixed venous oxygen saturation by 16% (p<.02) and decreased pulmonary vascular resistance by 15% (p<.02).

Both isoprenaline and dopamine improve stroke volume by an inotropic action, with an increase in venous return in the case of the latter and a reduction in afterload in the former.

It is cocluded that the usefulness of dopamine in septic shock may be limited in patients with previous myocardial disease because of the risk of increasing preload and in hypoxaemic patients because of the risk of increasing intrapulmonary shunting.

Key words

Dopamine Isoprenaline Septic shock Cardiac failure 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abrahamsen, A. M., Storstein, L., Westlie, L., Storstein, O.: Effects of dopamine on haemodynamics and renal function. Acta med. scand. 195, 365 (1974)PubMedGoogle Scholar
  2. 2.
    Beregowich, J., Bianchi, C., Rubler, S., Lomnitz, E., Gagin, N., Levitt, B.: Dose related haemodynamic and renal effects of dopamine in congestive heart failure. Amer. Heart. J. 87, 550 (1974)PubMedGoogle Scholar
  3. 3.
    Berk, J. L.: Use of vasco-active drugs in the treatment of shock. Surg. clin. N. Amer. 55, 721 (1975)PubMedGoogle Scholar
  4. 4.
    Enrico, J. F., Hadron, R., Poli, S., Perret, Cl.: Intérêt de l'exploration hémodynamique au cours du choc septique Jornées de Réanimation de Claude Bernard, 7 ème vol, pp. 123–148. Paris: Arnette édit. 1971Google Scholar
  5. 5.
    Goldberg, L. I.: Dopamine, clinical uses of an endogenous catecholamine. New Engl. J. Med. 291, 707 (1974)PubMedGoogle Scholar
  6. 6.
    Goulon, M., Gajdos, P., Barois, A., Babinet, P., Margent, P., Hincky, J. M., Perret, C., Enrico, J. F., Gardaz, J. P., Baguet, J. C., Neury, N.: Physiopathologie et traitement de l'état de choc au cours des infections péritonéales aiguës. In: Peritonites aigues et Réanimation, Expansion Scientifique edit., Soc. Rea. Langue Francaise, Juin 1973, 31Google Scholar
  7. 7.
    Holloway, E. L., Stinson, E. B., Derky, G. C., Harrison, D. C.: Action of drugs in patients early after cardiac surgery. Comparison of isoproterenol and dopamine. Amer. J. Cardiol. 35, 656 (1975)PubMedGoogle Scholar
  8. 8.
    Holzer, J., Karliner, J. S., O'Rourke, R. A., Pitt, W., Ross, J.: Effectiveness of dopamine in patients with cardiogenic shock. Amer. J. Cardio. 32, 79 (1973)Google Scholar
  9. 9.
    Horwitz, D. W., Fox, S. M., Goldberg, L. I.: Effects of dopamine in man. Circulat. Res. 10, 237 (1962)PubMedGoogle Scholar
  10. 10.
    Karliner, J. S.: Dopamine for cardiogenic shock. J. Amer. Med. Ass. 226, 1217 (1976)Google Scholar
  11. 11.
    Levine, P. A., McGillovary, M., Klein, M. D., Faxon, D., Ryan, T. J.: Dopamine dose in cardiogenic shock. Circulation 52, suppl. II. 208 (1975) (abs. no 824)PubMedGoogle Scholar
  12. 12.
    Loeb, H. S., Bredakis, J., Gunnar, R.: Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with cardiac failure. Circulation 52, suppl. II, 76 (1975) (abs. no 295)Google Scholar
  13. 13.
    Loeb, H. S., Winslow, E. B. J., Rahimtoola, S. H., Rosen, K. M., Gunnar, R. M.: Acute haemodynamic effects of dopamine in patients with shock. Circulation 44, 163 (1971)PubMedGoogle Scholar
  14. 14.
    Mac Cannell, K. L., McNay, J. L., Meyer, M. B., Goldberg, L. I.: Dopamine in the treatment of hypotension and shock. New Engl. J. Med. 275, 1389 (1966)PubMedGoogle Scholar
  15. 15.
    Marino, R. J., Romagnoli, A., Keats, A.: Selective veno constriction by dopamine in comparison with isoproterenol and phenylephrine. Anesthesiology 43, 570 (1975)PubMedGoogle Scholar
  16. 16.
    Siegel, J. H., Greenspan, M., Delguercio, L. M. M.: Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann. Surg. 165, 504 (1967)PubMedGoogle Scholar
  17. 17.
    Talley, R. C., Goldberg, L. I., Johnson, C. E., McNay, J. L.: A haemodynamic comparison of dopamine and isoproterenol in patients in shock. Circulation 24, 361 (1969)Google Scholar
  18. 18.
    Winslow, E. S., Loeb, H. S., Rahimtoola, S. N., Kamath, S., Gunnar, R. M.: Haemodynamic studies and results of therapy in 50 patients with bacteremic shock. Amer. J. Med. 54, 421 (1973)PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • B. Regnier
    • 1
  • M. Rapin
    • 1
  • G. Gory
    • 1
  • F. Lemaire
    • 1
  • B. Teisseire
    • 1
  • A. Harari
    • 1
  1. 1.Service de Réanimation Médicale et Laboratoire d'Exploration Fonctionnelle, Hôpital Henri MondorUniversité Paris-Val de MarneCreteilFrance

Personalised recommendations